Acute Biphenotypic Leukemia: Clinical Trials

2 trials for Acute Biphenotypic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1

Follow Acute Biphenotypic Leukemia: new trials by email Literature Review of Acute Biphenotypic Leukemia trials Research Report on Acute Biphenotypic Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia
Not applicableNot yet recruitingOssium Health, Inc.3002026-12-012026-09-10
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
Laboratory Biomarker Analysis, Liposomal Cytarabine-Daunorubicin CPX-351 - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia
Not applicableCompletedFred Hutchinson Cancer Center482013-05-072018-05-25

Narrower conditions

Leukemia, Biphenotypic, Acute (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)

Interventions

CPX-351 (1)  ·  Injections (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  Ossium Health, Inc. (1)

Countries

United States (1)

Top investigators

Roland Walter (1)

NIH funding

P30CA015704 (1)